Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-0.43%
operating margin TTM
4.14%
revenue TTM
1.52 Billion
revenue per share TTM
19.68$
valuation ratios | |
|---|---|
| pe ratio | -216.23 |
| peg ratio | -2.16 |
| price to book ratio | 0.97 |
| price to sales ratio | 0.93 |
| enterprise value multiple | -0.99 |
| price fair value | 0.97 |
profitability ratios | |
|---|---|
| gross profit margin | 55.18% |
| operating profit margin | 4.14% |
| pretax profit margin | -1.13% |
| net profit margin | -0.43% |
| return on assets | -0.17% |
| return on equity | -0.37% |
| return on capital employed | 2.14% |
liquidity ratio | |
|---|---|
| current ratio | 1.17 |
| quick ratio | 0.71 |
| cash ratio | 0.27 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 216.95 |
| operating cycle | 278.68 |
| days of payables outstanding | 41.71 |
| cash conversion cycle | 236.96 |
| receivables turnover | 5.91 |
| payables turnover | 8.75 |
| inventory turnover | 1.68 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.49 |
| debt equity ratio | 1.28 |
| long term debt to capitalization | 0.44 |
| total debt to capitalization | 0.56 |
| interest coverage | 0.94 |
| cash flow to debt ratio | 0.07 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.19 |
| cash per share | 3.55 |
| operating cash flow per share | 1.68 |
| free cash flow operating cash flow ratio | 0.12 |
| cash flow coverage ratios | 0.07 |
| short term coverage ratios | 0.21 |
| capital expenditure coverage ratio | 1.13 |
Frequently Asked Questions
When was the last time Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported earnings?
Integra LifeSciences Holdings Corporation (IART) published its most recent earnings results on 04-11-2024.
What is Integra LifeSciences Holdings Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Integra LifeSciences Holdings Corporation (NASDAQ:IART)'s trailing twelve months ROE is -0.37%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Integra LifeSciences Holdings Corporation (IART) currently has a ROA of -0.17%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IART's net profit margin stand at?
IART reported a profit margin of -0.43% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IART's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.17 in the most recent quarter. The quick ratio stood at 0.71, with a Debt/Eq ratio of 1.28.